SunOpta (NASDAQ:STKL) Bolsa

SunOpta

SunOpta Inc is a Canadian company that focuses on a healthy product portfolio. The company is a manufacturer for natural and private label brands and also produces its own propriety brands, including SOWN, Dream and West Life. The core of its product portfolio is a range of plant-based beverages, including oat, almond, soy, coconut and rice milks and creamers, which have a favorable climate profile relative to traditional dairy milks in terms of lower carbon emissions and water usage. Their plant-based offerings include non-genetically modified, organic, and gluten-free products. The consumer products portfolio also includes protein shakes, teas, broths, and fruit snacks. Geographically, the company operates in U.S, Canada and Others, out of which it derives maximum revenue from U.S.

SunOpta Inc

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining over 300 points on Thursday.
The Dow traded up 1.50% to 41,729.20 while the NASDAQ gained 1.91% to 18,076.43. The S&amp;P 500 also rose, gaining, 1.44% to 5,712.61.
Check This Out: <a href="https://www.benzinga.com/25/05/45283111/uber-to-rally-around-20-here-are-10-top-analyst-forecasts-for-thursday">Uber To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Thursday</a>
Leading and Lagging Sectors Energy shares rose by 1.2% on Thursday.
In trading on Thursday, health care stocks fell by 0.9%.
Top Headline
US Foods Holding Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USFD#NYSE">USFD</a>) reported weaker-than-expected earnings for the first quarter on Thursday.
The company posted quarterly earnings of 68 cents per share which missed the analyst consensus estimate of 69 cents per share. The company reported quarterly sales of $9.35 billion which missed the analyst consensus estimate of $9.38 billion.
Equities Trading UP &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<ul>
<li>SunOpta Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) shares shot up 30% to $5.91 after the company reported better-than-expected first-quarter financial results and raised its FY25 sales guidance above estimates. Additionally, the company announced a $25 million share repurchase program.</li>
<li>Shares of Sezzle Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) got a boost, surging 44% to $76.07 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance.</li>
<li>Solidion Technology Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STI#NASDAQ">STI</a>) shares were also up, gaining 37% to $0.13 after the company presented its patented technology for transforming lithium-ion facilities into battery producers.</li>
</ul>
Equities Trading DOWN
<ul>
<li>argenx SE &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) shares dropped 15% to $531.86 &nbsp;following first-quarter results.</li>
<li>Shares of Vor Biopharma Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VOR#NASDAQ">VOR</a>) were down 68% to $0.1725 after the company announced exploration of strategic alternatives to maximize shareholder value.</li>
<li>ADMA Biologics Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) was down, falling 19% to $19.09 following downbeat quarterly results.</li>
</ul>
Commodities In commodity news, oil traded up 2.4% to $59.48 while gold traded down 1% at $3,357.70.
Silver traded up 0.1% to $32.825 on Thursday, while copper fell 0.5% to $4.6385.
Euro zone
European shares were mostly higher today. The eurozone's STOXX 600 gained 0.37%, while Spain's IBEX 35 Index fell 0.13%. London's FTSE 100 slipped 0.30%, Germany's DAX 40 rose 0.77% and France's CAC 40 gained 0.84% during the session.
Asia Pacific Markets
Asian markets closed mixed on Thursday, with Japan's Nikkei gaining 0.41%, Hong Kong's Hang Seng Index gaining 0.37%, China's Shanghai Composite Index rising 0.28% and India's BSE Sensex falling 0.51%.
Economics
<ul>
<li>U.S. initial jobless claims declined by 13,000 to 228,000 in the week ending May 3, compared to market estimates of 230,000.</li>
<li>U.S. labor productivity in the nonfarm business sector declined by 0.8% during the first quarter compared to estimates of a 0.7% drop.</li>
<li>U.S. unit labor costs increased by 5.7% in the first quarter of compared to market estimates of a 5.1% gain. </li>
</ul>
Now Read This:
<ul>
<li> <a href="https://www.benzinga.com/news/earnings/25/05/45284390/how-to-earn-500-a-month-from-mckesson-stock-ahead-of-q4-earnings">How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings</a> </li>
</ul>
Photo via Shutterstock

Earnings

News

Eurozone

Intraday Update

Markets

Trading Ideas

ADMA

ARGX

SEZL

STKL

USFD

Crude Oil Gains Over 2%; US Foods Posts Downbeat Earnings

U.S. stocks were higher, with the Nasdaq Composite gaining around 100 points on Thursday.
Shares of Groupon, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRPN#NASDAQ">GRPN</a>) rose sharply during Thursday's session after the company reported <a href="https://in.benzinga.com/news/earnings/25/05/45285163/groupon-q1-billings-sees-double-digit-growth-in-north-america-guides-q2-above-consensus">better-than-expected first-quarter financial results.</a>
The company reported revenue of $117.2 million, beating estimates of $115.5 million, according to Benzinga Pro. Groupon reported an EPS of 18 cents, versus estimates for a loss of 11 cents.
Groupon shares jumped 26.3% to $21.45 on Thursday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul>
<li>SunOpta Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) shares jumped 41.3% to $6.40 after the company reported better-than-expected first-quarter financial results and raised its FY25 sales guidance above estimates. Additionally, the company announced a $25 million share repurchase program.</li>
<li>Sezzle Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEZL#NASDAQ">SEZL</a>) gained 36.5% to $72.00 after the company reported better-than-expected first-quarter financial results and raised its FY25 guidance.</li>
<li>Dave Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DAVE#NASDAQ">DAVE</a>) rose 33.3% to $143.75 after the company reported strong first-quarter results and raised its FY25 sales guidance.</li>
<li>LegalZoom.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LZ#NASDAQ">LZ</a>) gained 30% to $9.42 after the company reported better-than-expected first-quarter sales results and issued second-quarter sales guidance with its midpoint above estimates. Also, the company issued FY25 sales guidance above estimates.</li>
<li>Regencell Bioscience Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGC#NASDAQ">RGC</a>) jumped 29% to $245.00.</li>
<li>QuidelOrtho Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QDEL#NASDAQ">QDEL</a>) gained 29% to $33.30 following upbeat quarterly earnings.</li>
<li>Alvotech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALVO#NASDAQ">ALVO</a>) gained 24% to $9.86 after the company reported better-than-expected first-quarter financial results.</li>
<li>D-Wave Quantum Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QBTS#NASDAQ">QBTS</a>) rose 22% to $8.41 after the company reported better-than-expected quarterly financial results.</li>
<li>Revolution Medicines, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RVMD#NASDAQ">RVMD</a>) jumped 15.5% to $43.39 following quarterly results.</li>
<li>AppLovin Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APP#NASDAQ">APP</a>) gained 15.5% to $350.42 after the company reported better-than-expected first-quarter financial results.</li>
<li>EPAM Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>) rose 14.8% to $182.95 after the company reported better-than-expected first-quarter financial results and issued second-quarter adjusted EPS guidance above estimates. Also, the company raised its FY25 guidance.</li>
<li>Watts Water Technologies, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WTS#NYSE">WTS</a>) gained 10.7% to $234.35 following strong quarterly results.</li>
<li>SharkNinja, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SN#NYSE">SN</a>) surged 10.1% to $89.36 after the company reported better-than-expected first-quarter financial results and raised its FY25 adjusted EPS guidance above estimates.</li>
<li>Axon Enterprise, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AXON#NASDAQ">AXON</a>) rose 9.6% to $659.40 after the company reported better-than-expected first-quarter financial results and raised FY25 sales guidance.</li>
<li>Carvana Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CVNA#NYSE">CVNA</a>) rose 9.1% to $282.76 after the company reported better-than-expected first-quarter financial results.</li>
<li>Warner Bros. Discovery, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WBD#NASDAQ">WBD</a>) jumped 7.5% to $9.20 following quarterly results.</li>
<li>Viatris Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTRS#NASDAQ">VTRS</a>) gained 7.6% to $9.26 after the company reported better-than-expected first-quarter financial results and raised its FY25 adjusted EPS guidance.</li>
<li>MercadoLibre, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) gained 7% to $2,418.76 after the company reported better-than-expected first-quarter financial results.</li>
<li>Paycom Software, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PAYC#NYSE">PAYC</a>) rose 5.9% to $242.05 following upbeat quarterly results.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/05/45284390/how-to-earn-500-a-month-from-mckesson-stock-ahead-of-q4-earnings">How To Earn $500 A Month From McKesson Stock Ahead Of Q4 Earnings</a> </li>
</ul>
Photo via Shutterstock

Movers

ALVO

AXON

CVNA

DAVE

EPAM

GRPN

MELI

PAYC

QBTS

QDEL

RVMD

VTRS

Groupon Posts Upbeat Earnings, Joins Axon Enterprise, Warner Bros. Discovery, MercadoLibre And Other Big Stocks Moving Higher On Thursday

WIIM

SunOpta shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance above estimates. Additionally, the company announced a $25 million share repurchase program.

Buybacks

SunOpta Announces Share Repurchase Authorization Of Up To $25M

SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) raises FY2025 sales outlook from $775.00 million-$805.00 million to $788.00 million-$805.00 million vs $786.69 million estimate.

Guidance

SunOpta Raises FY2025 Sales Guidance from $775.00M-$805.00M to $788.00M-$805.00M vs $786.69M Est

SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.01 by 300 percent. This is a 100 percent increase over earnings of $0.02 per share from the same period last year. The company reported quarterly sales of $201.60 million which beat the analyst consensus estimate of $194.55 million by 3.62 percent. This is a 10.26 percent increase over sales of $182.85 million the same period last year.

Earnings Beats

SunOpta Q1 Adj. EPS $0.04 Beats $0.01 Estimate, Sales $201.60M Beat $194.55M Estimate

ACAD

ACDC

ACRE

ACVA

ADNT

ADTN

AIRG

ALNT

ALTG

ALTO

AMPH

AMPL

AMRK

AMRN

AOSL

APLS

ARIS

ARMN

ASLE

Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share

AVDL

AVDX

AXTA

AZTA

BAND

BBDO

BBGI

BBSI

BGSF

Brighthouse Financial, Inc. - Common Stock

BLBD

BLMN

BLZE

BMBL

BRKR

BROS

BTMD

BXSL

BYND

CAPL

CCSI

CDLX

CENT

CENTA

CENX

CEVA

CIVI

CMTG

CNDT

COHR

Core Scientific, Inc. - Class A Common Stock

CORZ

CPRX

CRNC

CRNT

CSGS

CSTE

CTVA

CYRX

Earnings Scheduled For May 7, 2025

DA Davidson analyst Brian Holland upgraded Utz Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UTZ#NYSE">UTZ</a>) from Neutral to Buy on Thursday, <a href="https://www.benzinga.com/quote/UTZ/analyst-ratings" target="_blank" rel="noreferrer noopener">maintaining the price forecast of $16.</a>
The analyst sees a compelling &#8220;risk-reward&#8221; setup for Utz Brands despite broader challenges in the food sector.
Holland highlights several supportive factors, including a firming position in the salty snacks category, which benefits from reduced promotional pressure and Utz Brands&#8217; strong performance in non-tracked retail channels.
Additionally, the company has exceeded expectations in transforming its supply chain, potentially setting the stage for upward earnings revisions if its recent market share gains continue.
Also Read: <a target="_blank" href="https://www.benzinga.com/25/04/44988897/china-trade-war-4-big-brand-stocks-that-will-suffer-most" rel="noreferrer noopener">China Trade War: 4 Big-Brand Stocks That Will Suffer Most</a>
The analyst also notes that, aside from names like Freshpet, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FRPT#NASDAQ">FRPT</a>) and SunOpta, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>), no other food stock is currently trading at &#8220;a wider relative valuation gap.&#8221;
The company released<a target="_blank" href="https://www.benzinga.com/pressreleases/25/04/b44861060/utz-appoints-william-j-kelley-jr-as-chief-financial-officer" rel="noreferrer noopener"> 1Q25 preliminary results released last week.</a>
Although overall sales in the salty snack category have remained weak due to inflation-driven volume pressure, growing health consciousness, and possible impacts from GLP-1 usage, the analyst notes that Utz Brands has steadily gained market share.
This modest but consistent share growth has been driven by expanded distribution, increased marketing efforts, and product innovation targeting largely untapped markets—particularly in regions that account for over 60% of salty snack sales.
While competitive promotions, especially from dominant players like Frito-Lay, created challenges through 2024, the lack of sustained volume gains from those promos led to a market reset, the analyst writes.
Price Action: Utz shares are trading higher by 1.61% to $13.60 at last check Thursday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/earnings/25/04/44989420/vinfast-auto-maintains-ev-delivery-outlook-amid-macro-uncertainty-despite-q4-margin-drag" target="_blank" rel="noreferrer noopener">VinFast Auto Maintains EV Delivery Outlook Amid Macro Uncertainty Despite Q4 Margin Drag</a></li>
</ul>
Image: Shutterstock

Equities

Analyst Ratings

General

FRPT

Utz Brands Gets Analyst Upgrade As Salty Snacks Gain Traction, Promotions Ease

SunOpta shares are trading lower. The company reported Q4 financial results.

SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) sees FY2025 sales of $775.000 million-$805.000 million vs $788.96 million analyst estimate.

SunOpta Sees FY2025 Sales $775.000M-$805.000M vs $788.96M Est

SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) reported quarterly earnings of $0.06 per share which beat the analyst consensus estimate of $0.05 by 20 percent. This is a 20 percent increase over earnings of $0.05 per share from the same period last year. The company reported quarterly sales of $193.91 million which beat the analyst consensus estimate of $191.63 million by 1.19 percent. This is a 6.76 percent increase over sales of $181.62 million the same period last year.

SunOpta Q4 Adj $0.06 Beats $0.05 Estimate, Sales $193.91M Beat $191.63M Estimate

AAOI

ABEV

ACMR

ALEC

AMBA

AMBC

AMSF

ARDT

ARHS

ARKO

ASTE

ATEC

AVNS

BATRA

BATRK

CDNA

CERT

CLDT

CLPT

COCO

COMM

CORT

CRGY

CSAN

CTRI

DHIL

DMRC

DOLE

DORM

EBAY

ECPG

EHTH

ENIC

ENOV

ERII

ESCA

ESTA

EVTC

FTAI

FWRD

GERN

GOGL

GSX Techedu Inc. American Depositary Shares

GOTU

GRBK

HCAT

HNST

IBTA

IMCR

Earnings Scheduled For February 26, 2025

Stephens &amp; Co. analyst Jim Salera reiterates SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) with a Overweight and maintains $10 price target.

Price Target

Reiteration

Stephens & Co. Reiterates Overweight on SunOpta, Maintains $10 Price Target

Stephens &amp; Co. analyst Jim Salera maintains SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) with a Overweight and raises the price target from $9 to $10.

Stephens & Co. Maintains Overweight on SunOpta, Raises Price Target to $10

SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. The company reported quarterly sales of $176.216 million which beat the analyst consensus estimate of $173.478 million by 1.58 percent. This is a 15.52 percent increase over sales of $152.541 million the same period last year.

SunOpta Q3 2024 Adj. EPS $0.02, Inline, Sales $176.216M Beat $173.478M Estimate

SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) affirms FY2024 sales outlook from $710.00 million-730.00 million to $710.00 million-730.00 million.

SunOpta Affirms FY2024 Sales Guidance from $710.00M-730.00M to $710.00M-730.00M

DA Davidson analyst Brian Holland maintains SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) with a Buy and maintains $9 price target.

DA Davidson Maintains Buy on SunOpta, Maintains $9 Price Target

U.S. stocks were higher, with the Dow Jones index gaining around 400 points on Monday.
Shares of Terns Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TERN#NASDAQ">TERN</a>) rose sharply in today's <a href="https://www.benzinga.com/quote/TERN/news">pre-market trading session.</a>
The company announced a top-line data from its Phase 1 randomized, double-blind, placebo-controlled single and multiple-ascending dose trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of TERN-601 dosed once-daily in healthy adults with obesity or overweight.
Terns Pharmaceuticals shares jumped 20.2% to $9.38 on Monday.
Here are some other big stocks recording gains in today's session.
<ul>
<li>Summit Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SMMT#NASDAQ">SMMT</a>) shares jumped 45.2% to $17.82 after the announced its lung cancer candidate has surpassed Merck&#8217;s multi-billion dollar Keytruda, cutting the risk of disease or death by half.</li>
<li>Relay Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RLAY#NASDAQ">RLAY</a>) gained 41% to $8.80 after the company reported interim data for its breast cancer treatment.</li>
<li>ADMA Biologics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADMA#NASDAQ">ADMA</a>) climbed 16.5% to $18.95 after it was announced the company will join the S&amp;P SmallCap 600.</li>
<li>Emerald Holding, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EEX#NYSE">EEX</a>) gained 15% to $6.16.</li>
<li>Stardust Power Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) climbed 14% to $7.90.</li>
<li>SunOpta Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) gained 13.4% to $6.36.</li>
<li>Mercer International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MERC#NASDAQ">MERC</a>) rose 12.8% to $6.41. Adient will replace Mercer International in the S&amp;P SmallCap 600.</li>
<li>Zurn Elkay Water Solutions Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZWS#NYSE">ZWS</a>) gained 12.6% to $33.46.</li>
<li>Applied Digital Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLD#NASDAQ">APLD</a>) jumped 11.8% to $5.09. Needham analyst John Todaro reiterated Applied Digital with a Buy and maintained a price target of $11.</li>
<li>Palantir Technologies Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NASDAQ">PLTR</a>) climbed 10.5% to $33.51 after the company announced an enterprise agreement with BP to extend their strategic relationship and introduce new artificial intelligence capabilities with Palantir&#8217;s AIP software.</li>
<li>Inspire Medical Systems, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INSP#NYSE">INSP</a>) gained 10.3% to $217.08 after it was announced the company will join the SmallCap 600.</li>
<li>Impinj, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PI#NASDAQ">PI</a>) gained 10.2% to $172.65 after it was announced the company will join the S&amp;P SmallCap 600.</li>
<li>Compass, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/COMP#NYSE">COMP</a>) rose 10.2% to $5.68.</li>
<li>Trump Media &amp; Technology Group Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DJT#NASDAQ">DJT</a>) gained 10% to $18.82.</li>
<li>ImmunityBio, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IBRX#NASDAQ">IBRX</a>) rose 9% to $3.6850 after the company presented long-term overall survival data in non-small cell lung cancer patients and announced registrational intent Phase 3 trials with ANKTIVA and checkpoint immunotherapy at the World Conference on Lung Cancer.</li>
<li>Hamilton Lane Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HLNE#NASDAQ">HLNE</a>) gained 7.9% to $157.26 after ht was announced the company will be added to the S&amp;P MidCap 400.</li>
<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) gained 6.6% to $121.81.</li>
<li>The Boeing Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) gained 3.7% to $163.55 following the announcement of a preliminary agreement between the company and its workers' union, potentially averting a strike that could have disrupted operations.</li>
<li>Tesla, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) rose 3.6% to $218.32 after its supplier Panasonic announced it completed preparations for mass production of high-capacity EV batteries. It&#8217;s set to produce 4680 cells at the Wakayama plant.</li>
</ul>
Now Read This: 
<ul>
<li><a href="https://editorial.benzinga.com/wp-admin/post.php?post=537615&amp;action=edit">McKesson, News Corporation And 2 Other Stocks Executives Are Selling</a></li>
</ul>

APLD

COMP

HLNE

IBRX

INSP

MERC

MSTR

PLTR

RLAY

SDST

SMMT

TERN

TSLA

Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday

SunOpta shares are trading higher after the company reported better-than-expected Q2 financial results and revised its FY24 revenue guidance above estimates.

SunOpta (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/STKL#NASDAQ">STKL</a>) reported quarterly earnings of $0.04 per share which beat the analyst consensus estimate of $0.00 by Infinity percent. The company reported quarterly sales of $171.000 million which beat the analyst consensus estimate of $158.927 million by 7.60 percent. This is a 17.71 percent decrease over sales of $207.809 million the same period last year.

SunOpta Q2 2024 Adj. EPS $0.04 Beats $0.00 Estimate, Sales $171.000M Beat $158.927M Estimate

Press Releases

SOWN® Oat Cold Foaming Cream Now Available on Amazon and at Sprouts Farmers Market

SunOpta Inc. to Participate in Upcoming Investor Conference

SunOpta Inc. Schedules Fourth Quarter and Fiscal 2024 Financial Results Release and Conference Call

SunOpta Announces Fourth Quarter and Fiscal 2024 Financial Results

SunOpta Inc. Schedules First Quarter 2025 Financial Results Release and Conference Call

SunOpta Inc. To Participate In Upcoming Investor Conference

SunOpta Releases 2024 Sustainability Report

Comments

SunOpta

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL